Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-1.12	82.33	-83.27
Graham Fair Price	24.06	70724.02	57008.69
PEG	313.30	0.09	-0.02
Price/Book	-10.06	0.36	0.40
Price/Cash Flow	76.14	-13.58	-56.93
Prices/Earnings	-39.31	4.66	7.68
Price/Sales	5.92	1.33	1.25
Price/FCF	76.14	-13.58	-56.93
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	617.87	0.07	< 0.005
Operating Margin	-95.12	< 0.005	-0.07
ROA	46.23	< 0.005	< 0.005
ROE	0.01	0.02	48.18
ROIC	-0.02	< 0.005	-89.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	-0.03	13.60
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.15	1.04	616.03
EPS QOQ	3.47	0.51	-85.32
FCF QOQ	-2.47	-2.84	-15.14
Revenue QOQ	0.06	-0.13	143.94
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	61.25	83.46	36.26
Days Sales Outstanding (DSO)	43.96	52.18	18.71
Inventory Turnover	1.47	1.08	-26.61
Debt/Capitalization	0.36	0.37	1.22
Quick Ratio	0.24	0.22	-8.80
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	105817.54	107841.03	1.91
Cash	5522.74	4089.63	-25.95
Capex	-1800.00	-1217.49	32.36
Free Cash Flow	-736.82	-2830.78	-284.19
Revenue	33492.10	28981.58	-13.47
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.65	0.65	-0.06
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-47.61	49.78	4.56
Naive Interpretation	Member

06 - Financial Health · Bad

Rating